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All that glitters may not be gold, but at least it contains free electrons.
John Desmond Baernal, Irish physicist (1901–1971)
Environews Forum
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Cancer and TCDD:
The Mitochondrial
Connection
During the Vietnam War, from 1961 to
1971, U.S. military forces sprayed millions
of gallons of the herbicide Agent Orange
over vast tracts of Southeast Asian jungle,
mainly in an effort to remove foliage and
expose enemy troops. Troops were exposed to
TCDD that contaminated the Agent
Orange, and since the 1970s, elevated blood
TCDD concentrations have been implicated
in many cancers, skin rashes, and other
health problems experienced by Vietnam
veterans. Although TCDD is carcinogenic, it
is not directly genotoxic. A report in the
8 January 2008 Proceedings of the National
Academy of Sciences now demonstrates one of
the ways that TCDD may promote cancer’s
growth and spread. 
The new study describes a novel mecha-
nism of TCDD action that focuses on the
mitochondria: “We found that TCDD
induces tumor cell proliferation and invasion
by directly acting on mitochondrial tran-
scription machinery and inducing mito-
chondrial respiratory stress,” says principal
investigator Narayan G. Avadhani, a bio-
chemistry professor at the University of
Pennsylvania. Such mitochondrial dysfunc-
tion inhibits apoptosis in malignant cells and
increases the invasive potential of cancer.
Mitochondrial dysfunction is also associated
with conditions such as heart disease, dia-
betes, obesity, blindness, deafness, kidney
disease, and neurodegenerative disorders, as
well as with aging.
“[The respiratory stress-signaling] cas-
cade culminates in the activation of a large
number of nuclear genes that affect various
cellular processes including cell metabolism,
proliferation, and apoptosis,” says lead
author Gopa Biswas, a researcher in Avad-
hani’s lab. “We have now established that
TCDD alters cellular morphology and phys-
iology through a similar mechanism.”
It is generally accepted that adverse
effects of TCDD result from its activation of
the Ah receptor, with effects occurring at very
low exposures. In the presence of TCDD, the
Ah receptor has been shown to either induce
or suppress the transcription of numerous
genes that have been linked with cancer
development via changes in tumor suppres-
sor proteins, oncogenes, growth factors, and
cell cycle proteins, among other factors. 
Mitochondrial dysfunction may entail a
more fundamental mechanism. It appears
that TCDD-induced mitochondrial stress
signaling in cancer cells is propagated in
part through the Ah receptor but also acts
through mechanisms that are independent
of the Ah receptor, such as by inducing pro-
tein kinase C and extracellular signal–regu-
lated kinases. 
“Our findings show that at subtoxic lev-
els of ten to fifty nanomolar, TCDD is suffi-
cient to cause mitochondrial dysfunction
and induce the signaling cascade,” says
Avadhani. “These results raise concerns over
the adverse health implications of dioxins
and PCBs even at very low levels.” 
In both animal and human studies
(notably epidemiologic analyses of cancer
rates following the 1976 industrial accident
in Seveso, Italy), TCDD exposure has
increased cancer incidence and mortality at
all cancer sites rather than at a few specific
sites. In 1997, the International Agency for
Research on Cancer upgraded TCDD to a
Group 1 human carcinogen on the basis of
mechanistic data. Considering subsequent
dose–response assessments for TCDD and
cancer, Kyle Steenland, a professor of envi-
ronmental and occupational health at Emory
University, and colleagues argued in the
September 2004 issue of EHP that “TCDD
exposure levels close to those in the general
population may be carcinogenic and argue
for caution in setting the upper ranges of
long-term permissible exposure to dioxins.”
The present study is limited in that it
involved skeletal myoblasts, not living organ-
isms. “These findings are significant but
unfortunately provide no in vivo data show-
ing tumor progression in animals due to loss
of mitochondrial function by TCDD,” says
Keshav K. Singh, a cancer geneticist at
Roswell Park Cancer Institute in Buffalo,
New York. “At a minimum, xenograft studies
in mice are needed.” Avadhani now plans to
study the precise mitochondrial targets of
different polychlorinated biphenyls (a related
group of compounds) that lead to reduced
mitochondrial transcription and then exam-
ine the implications of this pathway in tumor
progression in vivo. He sees possible implica-
tions for the prevention of breast, pancreatic,
and other endocrine cancers.
Recognition that the carcinogenic effects
of environmental toxicants may originate in
disruption of mitochondrial biology could
prove important for the future development
of cancer prevention and treatment proce-
dures related to TCDD and other dioxin
exposures. “The new findings suggest that
the risk of cancer may be reduced by avoid-
ing or lowering exposure to environmental
mitochondrial toxicants as well as [possibly]
by optimizing mitochondrial energy metab-
olism by nutritional and medicinal means,”
says Egil Fosslien, a pathology professor
emeritus at the University of Illinois at
Chicago. –M. Nathaniel Mead
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CHEMICAL EXPOSURES
A U.S. Air Force crew member stands by a defoliant mixing machine inside one of three C-123
aircraft used to clear jungle growth in South Vietnam; August 1963.T
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Toxicity Testing
Takes Stock 
Early February 2008 saw the celebration of
the first 10 years of work by the Interagency
Coordinating Committee on the Validation
of Alternative Methods (ICCVAM), the fed-
erally funded body charged with promoting
the regulatory acceptance of scientifically
valid safety testing methods that replace,
reduce, or refine the use of animals. ICCVAM
also released a five-year plan establishing pri-
orities for research, translation, and valida-
tion activities. The plan was unveiled during
an anniversary symposium held 5 February
2008 in Bethesda, Maryland.
ICCVAM conducts technical evalua-
tions of alternative testing methods proposed
for regulatory use, makes recommendations
to regulatory agencies on the usefulness and
limitations of new methods, identifies
knowledge and data gaps that need to be
addressed with further research and develop-
ment efforts, and coordinates with similar
efforts internationally. The National Toxico-
logy Program Interagency Center for the
Evaluation of Alternative Toxicological
Methods (NICEATM), housed at the
NIEHS, provides administrative, opera-
tional, and scientific support to the inter-
agency committee. 
To date, ICCVAM’s recommendations
have resulted in national and international
acceptance of alternatives for acute oral tox-
icity, skin corrosivity, and allergic contact
dermatitis, three of the most common types
of toxicity assays. ICCVAM has also recom-
mended use of the Bovine Corneal Opacity
and Permeability and Isolated Chicken Eye
tests to assess eye irritation; regulatory deci-
sions on these assays are due in April 2008.
William Stokes, director of NICEATM,
says the tests reviewed by ICCVAM are
essential to translating research findings
from bench to bedside. “Our ‘bedside’ is
more effective public health prevention
measures,” he says. “The improved alterna-
tives recommended by ICCVAM help pre-
vent disease and injury so you don’t end up
in the bed in the first place.”
“ICCVAM is essential,” says John
Bailey, executive vice president for science at
the Personal Care Products Council (for-
merly the Cosmetics, Toiletry, and Fragrance
Association). “It brings the science together,
and allows a transparent assessment.”
ICCVAM’s new five-year plan lists four
areas of emphasis: establishing priorities for
future testing; identifying and encouraging
appropriate research efforts; educating
stakeholders about the acceptance and
appropriate use of improved methods; and
improving partnerships with and between
those inside and outside ICCVAM. Some of
the approaches emphasized for further devel-
opment include high-throughput assays, use
of species such as roundworms and tadpoles,
and better biomarkers of toxic effects.
Despite the committee’s successes, ICCVAM’s
efforts have received mixed reviews. Jessica
Sandler, director of the Regulatory Testing
Division for People for the Ethical Treatment
of Animals, who strongly supported ICC-
VAM when it was formed, says progress has
been painfully slow. She attributes this in part
to ICCVAM not taking advantage of the
work of sister organizations such as the
European Centre for the Validation of
Alternative Methods (ECVAM), which has
endorsed the use of many more alternative
test methods than its U.S. counterpart.
But Stokes explains that ICCVAM,
NICEATM, and ECVAM in fact worked
very closely in recent years. ICCVAM’s activ-
ities are limited to the review of test methods
applicable to regulatory testing, while ECVAM
has a broader mandate to address animal use
for all areas of research and testing (e.g.,
screening to prioritize chemicals for product
development). Stokes notes that ECVAM is a
center with numerous laboratories and a large
full-time staff, whereas ICCVAM is a com-
mittee with no laboratories. ICCVAM must
also operate with a high level of transparency
and the opportunity for broad public and
stakeholder input in contrast to ECVAM’s
less-extensive closed review process. More-
over, Stokes says, many of the assays recom-
mended by ECVAM have not been accepted
by European regulatory agencies. 
Daniel Krewski, chairman of a National
Research Council committee that produced
the 12 June 2007 report Toxicity Testing in
the 21st Century, affirms the value of
ICCVAM’s work so far. However, the com-
mittee recommends that an entirely different
federal framework, possibly with a size and
budget akin to that of the National
Toxicology Program, be rapidly adopted to
overcome ICCVAM’s limitations. Such a
program would be “quite a paradigm shift
from what we’re doing now,” he says, but
ICCVAM could be viewed as a transitional
step toward this new direction.
Meanwhile, the new five-year plan may
help expedite improvements, says Sonya
Lunder, a senior analyst with the Environ-
mental Working Group. She has many con-
cerns about the ICCVAM review process
but appreciates the plan: “It gives us a bench-
mark to measure progress.” The plan is avail-
able at http://iccvam.niehs.nih.gov/docs/
5yearplan.htm. –Bob Weinhold
Savory Relief for Arsenic
Poisoning?
In the February 2008 issue of Food and Chemical
Toxicology, researchers from India report that
aqueous garlic extract (AGE) fed to at-risk
individuals may reduce the toxic effects of arsenic.
Rats receiving daily doses of
arsenic equivalent to the
levels in groundwater from
heavily arsenic-
contaminated areas of
the Bengal Basin
retained significantly
less of the element in
blood and liver and
excreted significantly
more in urine when
fed 2 mg/mL AGE. The
researchers believe the
antioxidant properties of
garlic, along with the chelating
efficacy exhibited, led to the success of the
treatment. AGE was also seen to significantly
reduce intracellular reactive oxygen species in
several cell types.
In Utero Cigarette Smoke
Exposure and Age at Menopause
It is well documented that women who smoke
cigarettes begin menopause earlier than
nonsmokers. Using data from a U.S. national study
on the health effects of prenatal diethylstilbestrol
exposure, a team of researchers reported in the
11 January 2008 advance access edition of the
American Journal of Epidemiology that study
participants who had never smoked cigarettes but
had been prenatally exposed to maternal cigarette
smoke experienced earlier-onset menopause.
Moreover, previously noted associations between
current smoking and age at menopause were not
observed among these women. 
Antibiotic Resistance Seen in
Arctic Wildfowl
Swedish researchers reported in the January 2008
issue of Emerging Infectious Diseases that birds
living in three different geographic regions of the
Arctic tundra carry E. coli bacteria resistant to
multiple types of antibiotics. These birds, which lived
in northeastern
Siberia, northern
Alaska, and northern
Greenland, are
believed to have had
no contact with
humans. The
researchers proposed
three possible
explanations for their
findings: the birds
could have been
exposed to the
bacteria through
contact with other
species of birds migrating from other regions, or
resistance could have developed either through
spontaneous mutations or through horizontal gene
transfer from other microbes.
Forum
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ALTERNATIVE TEST MODELS
The western sandpiper, one of 
the Arctic species studiedJ
o
s
e
p
h
 
T
a
r
t
/
E
H
P
/
i
s
t
o
c
k
Hard Data for Hard Water 
Are people who drink “hard” water containing higher levels of calci-
um and/or magnesium less likely to suffer cardiovascular disease?
This is the question that delegates who attended a World Health
Organization (WHO) meeting 21–22 January 2008 in Geneva,
Switzerland, are now trying to answer once and for all. 
The idea that hard water—particularly that with higher magne-
sium concentrations—helps ward off cardiovascular problems has
been around for 50 years. However, due to the ecologic nature of
most studies, uncontrolled confounding factors, and the different
variables and outcomes measured, no firm conclusions have ever
been drawn. The WHO is therefore coordinating worldwide efforts
to compare cardiovascular morbidity before and after changes in the
calcium/magnesium content of water supplies. 
The aim of the Geneva meeting was to discuss how such a
study—ultimately a composite of many smaller studies from differ-
ent nations—should be performed. “A prospective, multi-country
study following a single protocol would be the best way to ensure a
sufficiently large sample for overall analysis . . . if we are to make
meaningful comparisons,” says Paul Hunter, a professor of health
protection at the University of East Anglia, United Kingdom, whose
group has been testing a possible protocol. 
Hunter’s work involved obtaining mortality and residence data
on individuals in areas where notable changes in water hardness had
occurred through the introduction or cessation of softening practices,
allowing trends in cardiovascular mortality before and after the
change in water hardness to be detected. 
Controlling the confounding factors in a final meta-analysis
involving populations from different countries could pose problems,
but “the ‘before and after’ nature of the individual studies should cer-
tainly provide meaningful results at the population level,” he says.
The mechanism by which hard water may provide protection
against cardiovascular disease remains a matter of debate. The extra
calcium it carries could help
reduce blood pressure, whereas
low serum magnesium concen-
trations—common to people
living in soft-water areas—
appear linked with arrhythmias.
“Couple this with the fact that
many of today’s refined foods
are low in magnesium, that
many people in developed
countries either do not cover or only barely cover their magnesium
needs, and that magnesium in drinking water is more bioavailable
than that in food, and you can see how [even the relatively small]
extra supply of this mineral to people in hard-water areas could be
beneficial,” says Frantisek Kozísek, head of the National Reference
Centre for Drinking Water in Prague, Czech Republic. “Cooking
food in soft water also tends to remove magnesium, calcium, and
other essential elements from food, making matters worse.”
The results could lead to countries adopting legislation to supple-
ment drinking water supplies in soft-water areas with calcium and
magnesium. Kozísek has already proposed that levels of calcium and
magnesium in drinking water be set at 40–80 mg/L and 20–30
mg/L, respectively. “The available evidence suggests these ranges
could be beneficial, and . . . there is no evidence that harder water
causes any harm,” he explains.
Regu Regunathan, a consultant for the Water Quality
Association, says that any recommendations on magnesium or other
minerals must be based on absolutely solid data; otherwise, desalina-
tion plants and industries providing water softeners and reverse
osmosis devices could be needlessly affected. Indeed, soft water has
palpable technical advantages over hard water, including reduced
scaling in appliances, pipes, and on surfaces, as well as better soap
lathering. To this, Kozísek responds, “If health and technical aspects
of water are in contradiction, then cost–benefit analyses of the con-
sequences of both aspects should be made to decide what is more
important for society.” –Adrian Burton
A 114 VOLUME 116 | NUMBER 3 | March 2008 • Environmental Health Perspectives
Dairy Paradox
The etiology of colorectal disease revolves
around genetic and environmental factors,
particularly diet. A meta-analysis in the
7 July 2004 issue of the Journal of the
National Cancer Institute suggested that con-
suming more dairy products and calcium
may reduce colorectal cancer risk, but epi-
demiologic studies on this link have yielded
inconsistent results. One explanation for
this inconsistency may be the timing of
exposure: cancer develops over decades, and
early-life exposures to carcinogens and
growth factors could be a critical factor. A
new study designed to address this possibil-
ity has found that adults who consumed
more dairy during childhood may have a
greater risk of developing colorectal cancer
in adulthood. The results appear in the
December 2007 issue of the American
Journal of Clinical Nutrition.
Colorectal cancer is among the leading
causes of mortality in developed countries;
according to the National Cancer Institute,
about 630,000 deaths were expected to
occur worldwide in 2007. Even moderate
changes in diet and lifestyle could prevent at
least 70% of all colorectal cancer cases,
according to a review in the December 2002
Gastroenterology Clinics of North America.
The main culprits appear to be excessive
caloric intake, as well as frequent consump-
tion of red meat, processed meats, alcohol,
and refined carbohydrates. 
The historical cohort study employed
data from the Carnegie Survey, conceptual-
ized by Sir John Boyd Orr, which recorded
food consumption patterns in 1,343 English
and Scottish families from 1937 to 1939.
The survey was designed to investigate the
long-range impact of children’s diet,
growth, living conditions, and health on
adult cardiovascular disease. 
Dietary data were obtained using a 7-
day household inventory; also, weighed
inventories of all foods in the household
were conducted at the start and end of the
survey period. The average follow-up time
for adults included in this study was 65 years;
4,374 individuals were available for follow-
up between 1948 and 2005. Daily intake of
dairy products ranged from less than 0.5 cup
at the lowest level to nearly 2 cups at the
highest; liquid milk constituted 94% of the
dairy intake. 
Those individuals who grew up in fami-
lies reporting the highest levels of dairy con-
sumption showed a nearly threefold increase
in the risk of colorectal cancer compared
with those from families reporting the lowest
intake. The elevated risk remained even after
the researchers adjusted the data for potential
confounders such as socioeconomic status
and meat, fruit, and vegetable intake. No
other cancers were significantly affected by
higher dairy intakes. 
“The mechanisms underlying these asso-
ciations remain unknown, but there is
increasing evidence that nutrition early in life
can have long-lasting programming effects,”
says lead author Jolieke C. van der Pols, an
epidemiologist at the University of Queens-
land. For example, childhood dairy intake
appears to be inversely associated with adult-
hood concentrations of insulin-like growth
CARDIOVASCULAR HEALTH
CANCER
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Forum The Beat
UK Organic Certifier Says No 
to Nanomaterials
The Soil Association, a nonprofit UK
organization that certifies the
majority of that nation’s organic
products, announced in January
2008 it will no longer allow
man-made nanomaterials
(materials with a mean size of
less than 200 nm) to be used in
goods carrying its certification
label. This rule, the first of its kind
in the world, will apply mainly to
personal care products but also could
apply to other categories such as food and textiles.
The group cites insufficient evidence on the impact of
nanomaterials on the environment and human health.
China Begins National Survey of
Pollution Sources
Although China has set goals to cut emissions of
major pollutants, emissions of sulfur dioxide and
some indicators of poor water quality increased in
2006. Experts have decried the lack of trustworthy
statistics on the sources and extent of pollution and
the number of remediation facilities. In response, the
Chinese government invested US$100 million in 2007
to launch the collection of data from industrial,
agricultural, and residential sources at sites
throughout China, beginning in February 2008. The
work, which is being overseen by the State
Environmental Protection Administration and the
Ministry of Agriculture, will also compile information
on methods of environmental remediation currently
available in the country. Data collection is projected
to be complete by mid-2008.
Ancient Chinese Cancer Secret?
Researchers at the University of Texas M.D. Anderson
Cancer Center are currently conducting clinical trials
in Shanghai on a cancer therapy that uses the venom
of the Asiatic toad (Bufo gargarizans). China’s use of
the venom in the treatment of a number of illnesses
can be traced back to the tenth century. In the
clinical trials, compounds from the venom have
proven beneficial and caused no apparent side
effects in patients with advanced liver, pancreatic, or
lung cancer. In mouse studies, the compound was
better at shrinking pancreatic tumors than
gemcitabine, a standard chemotherapy drug. Cardiac
glycosides in the venom are thought to inhibit
proteins that promote cancer cell growth, thereby
causing cancer cell death. Although potentially toxic
at high doses, these glycosides are used to treat
congestive heart failure. Currently, the venom-based
treatment is administered by injection, but the Texas
researchers hope to develop a pill form. 
European Chemicals Agency ehpnet
On 1 June 2007, Europe’s new legislation for managing chemicals, REACH
(Regulation, Evaluation, Authorisation and Restriction of Chemicals),
entered into force. Under the auspices of REACH, the European Chemicals
Agency (ECHA) was set up. ECHA’s scope involves implementing and man-
aging the technical, scientific, and administrative work of REACH as well as
working to ensure consistency among the European Union (EU) countries
with regard to the legislation. The Helsinki-based agency has established a
website at http://echa.europa.eu/ to provide a central online source for
news and information about its work.
The ECHA website has links to information for industry, policy makers,
and the general public about the scope of REACH. The REACH page on the
website takes visitors to the REACH Navigator, an interactive tool that
allows companies to learn more about their responsibilities regarding
REACH compliance. Companies find out what they need to do by answer-
ing a series of questions posed by the Navigator. The Frequently Asked
Questions section addresses general topics as well as questions about spe-
cific classes of chemicals. The Guidance section of the REACH page covers
the technical aspects of the legislation. Included here are documents
explaining the various REACH processes, including registration, data shar-
ing, classification of chemicals, and preparation of chemical safety reports. 
The Software Tools page of the ECHA website provides information on
REACH-IT and IUCLID 5. REACH-IT allows companies to set up webpages
through which they can submit their chemical registration information.
Personnel from ECHA and EU member states can use these pages to review
this information. REACH-IT also provides a means for companies that manu-
facture the same chemicals to contact one another, whereas members of the
public can use it to find out information on the types of chemicals that are
produced in the EU. IUCLID 5 is the International Uniform Chemical
Information Database, which companies can use to store and report infor-
mation on the properties of chemicals. IUCLID 5 uses data-gathering tem-
plates developed by the Organisation for Economic Co-operation and
Development. –Erin E. Dooley
factor 1 (IGF-1), a key player in the devel-
opment and progression of colorectal can-
cer. But it’s the effect of early dairy intake on
childhood (rather than on adult) concentra-
tions of IGF-1 that may be the important
mediator of colorectal cancer risk.
The findings seem perplexing given
previous research showing an association
between high dairy/calcium consumption
and lower risk of colorectal cancer in adult-
hood. “In adults, this protection occurs
despite the increase in growth factors,
which would be expected to increase risk,”
says epidemiologist Edward Giovannucci of
the Harvard School of Public Health. “It is
possible, though not proven, that the
increase in growth factors early in life may
be more important for colorectal cancer
risk.” Giovannucci asserts that the new
findings are biologically plausible and war-
rant efforts to replicate these findings in
other populations and settings.
Andrew Szilagyi, a gastroenterologist
and assistant professor of medicine at
McGill University School of Medicine,
points out the lack of data on adult dietary
intakes in the Boyd Orr cohort. “We do not
know any aspects of dietary intake in adult-
hood,” Szilagyi says. “Nor do we know that
the adults who developed colorectal cancer
were also the very children in the families
that indeed had higher dairy intakes.” In
light of the fact that most studies have
reported a protective effect of dairy prod-
ucts, it is important to determine the extent
to which the former diet was continued
into adulthood, he notes.
The milk consumption levels identified
as posing a significant cancer risk in the
Boyd Orr cohort are similar to current aver-
age intakes for U.S. children. Nonetheless,
the researchers assert that it would be pre-
mature to consider altering current guide-
lines for children’s nutrition. “Dairy prod-
ucts are important contributors to children’s
intake of protein, vitamins, and minerals,”
says van der Pols. “Because this is only the
first study to show associations between
childhood dairy consumption and risk of
cancer in adulthood, more evidence is need-
ed before any firm conclusions can be
drawn.” –M. Nathaniel Mead
Bufo gargarizans